Delta-24-RGD adenoviral therapy directs oncolytic and immune-mediated anti-tumor effects in recurrent malignant glioma patients

Jeffrey I. Traylor, John S. Kuo

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish (US)
Pages (from-to)E11-E12
JournalClinical Neurosurgery
Volume84
Issue number1
DOIs
StatePublished - Jan 1 2019

Fingerprint

Glioma
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Delta-24-RGD adenoviral therapy directs oncolytic and immune-mediated anti-tumor effects in recurrent malignant glioma patients. / Traylor, Jeffrey I.; Kuo, John S.

In: Clinical Neurosurgery, Vol. 84, No. 1, 01.01.2019, p. E11-E12.

Research output: Contribution to journalComment/debate

@article{179e82900a2244d9a5380e1a4ce2f1ec,
title = "Delta-24-RGD adenoviral therapy directs oncolytic and immune-mediated anti-tumor effects in recurrent malignant glioma patients",
author = "Traylor, {Jeffrey I.} and Kuo, {John S.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1093/neuros/nyy504",
language = "English (US)",
volume = "84",
pages = "E11--E12",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Delta-24-RGD adenoviral therapy directs oncolytic and immune-mediated anti-tumor effects in recurrent malignant glioma patients

AU - Traylor, Jeffrey I.

AU - Kuo, John S.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85059266010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059266010&partnerID=8YFLogxK

U2 - 10.1093/neuros/nyy504

DO - 10.1093/neuros/nyy504

M3 - Comment/debate

C2 - 30395338

AN - SCOPUS:85059266010

VL - 84

SP - E11-E12

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 1

ER -